Literature DB >> 35083827

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.

Theresa A McDonagh1, Marco Metra2, Marianna Adamo2, Roy S Gardner1, Andreas Baumbach1, Michael Böhm3, Haran Burri4, Javed Butler5, Jelena Čelutkienė6, Ovidiu Chioncel7, John G F Cleland1, Andrew J S Coats1, Maria G Crespo-Leiro8, Dimitrios Farmakis9, Martine Gilard10, Stephane Heymans11, Arno W Hoes11, Tiny Jaarsma12, Ewa A Jankowska13, Mitja Lainscak14, Carolyn S P Lam15, Alexander R Lyon1, John J V McMurray1, Alexandre Mebazaa10, Richard Mindham1, Claudio Muneretto2, Massimo Francesco Piepoli2, Susanna Price1, Giuseppe M C Rosano1, Frank Ruschitzka4, Anne Kathrine Skibelund16.   

Abstract

Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator) (Netherlands), P. Christian Schulze (CPG Review Coordinator) (Germany), Magdy Abdelhamid (Egypt), Victor Aboyans (France), Stamatis Adamopoulos (Greece), Stefan D. Anker (Germany), Elena Arbelo (Spain), Riccardo Asteggiano (Italy), Johann Bauersachs (Germany), Antoni Bayes-Genis (Spain), Michael A. Borger (Germany), Werner Budts (Belgium), Maja Cikes (Croatia), Kevin Damman (Netherlands), Victoria Delgado (Netherlands), Paul Dendale (Belgium), Polychronis Dilaveris (Greece), Heinz Drexel (Austria), Justin Ezekowitz (Canada), Volkmar Falk (Germany), Laurent Fauchier (France), Gerasimos Filippatos (Greece), Alan Fraser (United Kingdom), Norbert Frey (Germany), Chris P. Gale (United Kingdom), Finn Gustafsson (Denmark), Julie Harris (United Kingdom), Bernard Iung (France), Stefan Janssens (Belgium), Mariell Jessup (United States of America), Aleksandra Konradi (Russia), Dipak Kotecha (United Kingdom), Ekaterini Lambrinou (Cyprus), Patrizio Lancellotti (Belgium), Ulf Landmesser (Germany), Christophe Leclercq (France), Basil S. Lewis (Israel), Francisco Leyva (United Kingdom), AleVs Linhart (Czech Republic), Maja-Lisa Løchen (Norway), Lars H. Lund (Sweden), Donna Mancini (United States of America), Josep Masip (Spain), Davor Milicic (Croatia), Christian Mueller (Switzerland), Holger Nef (Germany), Jens-Cosedis Nielsen (Denmark), Lis Neubeck (United Kingdom), Michel Noutsias (Germany), Steffen E. Petersen (United Kingdom), Anna Sonia Petronio (Italy), Piotr Ponikowski (Poland), Eva Prescott (Denmark), Amina Rakisheva (Kazakhstan), Dimitrios J. Richter (Greece), Evgeny Schlyakhto (Russia), Petar Seferovic (Serbia), Michele Senni (Italy), Marta Sitges (Spain), Miguel Sousa-Uva (Portugal), Carlo G. Tocchetti (Italy), Rhian M. Touyz (United Kingdom), Carsten Tschoepe (Germany), Johannes Waltenberger (Germany/Switzerland) All experts involved in the development of these guidelines have submitted declarations of interest. These have been compiled in a report and published in a supplementary document simultaneously to the guidelines. The report is also available on the ESC website www.escardio.org/guidelines For the Supplementary Data which include background information and detailed discussion of the data that have provided the basis for the guidelines see European Heart Journal online.
© 2022 European Society of Cardiology This article has been co-published with permission in European Heart Journal (published by Oxford University Press on behalf of European Society of Cardiology) and European Journal of Heart Failure (published by John Wiley & Sons Ltd on behalf of European Society of Cardiology).

Entities:  

Keywords:  Guidelines; acute heart failure; advanced heart failure; arrhythmias; cardiac resynchronization therapy; comorbidities; diagnosis; ejection fraction; heart failure; hospitalization; mechanical circulatory support; multidisciplinary management; natriuretic peptides; neuro-hormonal antagonists; pharmacotherapy; transplantation

Mesh:

Year:  2022        PMID: 35083827     DOI: 10.1002/ejhf.2333

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  67 in total

1.  Application and evaluation of sacubitril/valsartan in patients with cardiac insufficiency during perioperative period of cardiac surgery.

Authors:  Wenxing Peng; Xiaoxi Li; Yang Lin
Journal:  Exp Ther Med       Date:  2022-06-08       Impact factor: 2.751

Review 2.  Frailty in older adults with heart disease.

Authors:  Peter Dovjak
Journal:  Z Gerontol Geriatr       Date:  2022-06-20       Impact factor: 1.292

3.  Evaluation of the HEFESTOS scale to predict outcomes in emergency department acute heart failure patients.

Authors:  Adriana Gil-Rodrigo; José María Verdú-Rotellar; Víctor Gil; Aitor Alquézar; Lluís Llauger; Pablo Herrero-Puente; Javier Jacob; Rosa Abellana; Miguel-Ángel Muñoz; María-Pilar López-Díez; Nicole Ivars-Obermeier; Begoña Espinosa; Beatriz Rodríguez; Marta Fuentes; Josep Tost; M Luisa López-Grima; Rodolfo Romero; Christian Müller; WFrank Peacock; Pere Llorens; Òscar Miró
Journal:  Intern Emerg Med       Date:  2022-08-29       Impact factor: 5.472

4.  Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry.

Authors:  Andrea Salzano; Roberta D'Assante; Eduardo Bossone; Alberto M Marra; Antonio Cittadini; Massimo Iacoviello; Vincenzo Triggiani; Giuseppe Rengo; Francesco Cacciatore; Ciro Maiello; Giuseppe Limongelli; Daniele Masarone; Angela Sciacqua; Pasquale Perrone Filardi; Antonio Mancini; Maurizio Volterrani; Olga Vriz; Roberto Castello; Andrea Passantino; Michela Campo; Pietro A Modesti; Alfredo De Giorgi; Michele Arcopinto; Paola Gargiulo; Maria Perticone; Annamaria Colao; Salvatore Milano; Agnese Garavaglia; Raffaele Napoli; Toru Suzuki
Journal:  Cardiovasc Diabetol       Date:  2022-06-16       Impact factor: 8.949

Review 5.  New Hypoglycemic Drugs: Combination Drugs and Targets Discovery.

Authors:  Xiayun Ni; Lei Zhang; Xiaojun Feng; Liqin Tang
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

Review 6.  The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.

Authors:  Frank R Heinzel; Sanjiv J Shah
Journal:  Herz       Date:  2022-06-29       Impact factor: 1.740

7.  Effects of Sacubitril/Valsartan on the Renal Resistance Index.

Authors:  Margherita Ilaria Gioia; Giuseppe Parisi; Dario Grande; Miriam Albanese; Gianmarco Alcidi; Michele Correale; Natale Daniele Brunetti; Marco Matteo Ciccone; Massimo Iacoviello
Journal:  J Clin Med       Date:  2022-06-26       Impact factor: 4.964

8.  Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats.

Authors:  Ying Luo; Jiaxian Chen; Yuewu Chen; Yangshen Su; Xiaoyan Wu; Wanling Zheng; Xianxia Liu; Lei Chen
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

9.  ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation.

Authors:  Stefania Angela Di Fusco; Edoardo Gronda; Edoardo Mocini; Fabiana Lucà; Irma Bisceglia; Leonardo De Luca; Pasquale Caldarola; Manlio Cipriani; Marco Corda; Alfredo De Nardo; Giuseppina Maura Francese; Cosimo Napoletano; Alessandro Navazio; Carmine Riccio; Loris Roncon; Emanuele Tizzani; Federico Nardi; Stefano Urbinati; Serafina Valente; Michele Massimo Gulizia; Domenico Gabrielli; Fabrizio Oliva; Giuseppe Imperoli; Furio Colivicchi
Journal:  Eur Heart J Suppl       Date:  2022-05-18       Impact factor: 1.624

10.  Heart failure and cognitive impairment: Complexity that requires a new approach.

Authors:  Lauren G Gilstrap; Eiran Z Gorodeski; Parag Goyal
Journal:  J Am Geriatr Soc       Date:  2022-04-15       Impact factor: 7.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.